In men with prostate cancer, prophylactic whole pelvic radiotherapy does not improve OS compared to prostate-only dose-escalated radiotherapy.

A black box warning is the FDA’s most stringent for a prescription drug or medical device. Since 2003, it has appeared on all estrogen menopause drugs. It warns of risks such as breast and uterine ...

(HealthDay News) — Incidence and mortality from renal cancer (RC) may double by 2050, according to a study published in the October issue of European Urology.

In a separate update, the CDC also accepted a panel recommendation that children under age 4 receive their first chickenpox (varicella) shot separately from the combined measles, mumps, rubella and ...

The Food and Drug Administration has approved Enoby, a biosimilar to Prolia, and Xtrenbo, a biosimilar to Xgeva.

Enhanced staffing and flexible resource allocation were key in managing patient surge after Oct. 7, 2023, attack in Southern Israel.

Investigators have developed a prognostic model that may identify which patients with MIBC are suitable for bladder-preserving chemoradiation.

In focus group interviews, married men with cancer reported better experiences for themselves and their caregivers with healthcare providers, compared with their single counterparts. Married men with ...

Recurrent prostate cancer patients with luminal B tumors may benefit from hormone therapy added to radiation following surgery.

Adjuvant radiotherapy improves locoregional failure-free survival, compared with observation, in patients with locally advanced MIBC.

The phase 2 EXTEND trial tested the progression-free survival (PFS) benefits of metastasis-directed therapy by solid tumor type.

Improving patients’ shared decision-making abilities in healthcare requires arming them with timely, accurate, patient-centered education.